These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38665842)

  • 1. Small molecules modulating RNA splicing: a review of targets and future perspectives.
    Bouton L; Ecoutin A; Malard F; Campagne S
    RSC Med Chem; 2024 Apr; 15(4):1109-1126. PubMed ID: 38665842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications.
    Sergeeva OV; Shcherbinina EY; Shomron N; Zatsepin TS
    Nucleic Acid Ther; 2022 Jun; 32(3):123-138. PubMed ID: 35166605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of pre-mRNA splicing by antisense oligonucleotides.
    Taylor JK; Dean NM
    Curr Opin Drug Discov Devel; 1999 Mar; 2(2):147-51. PubMed ID: 19649941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.
    Jyotsana N; Heuser M
    Expert Opin Ther Targets; 2018 Feb; 22(2):107-121. PubMed ID: 29235382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting splicing factors for cancer therapy.
    Bashari A; Siegfried Z; Karni R
    RNA; 2023 Apr; 29(4):506-515. PubMed ID: 36697261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than a messenger: Alternative splicing as a therapeutic target.
    Black AJ; Gamarra JR; Giudice J
    Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of computational and structural biology in the development of small-molecule modulators of the spliceosome.
    Rozza R; Janoš P; Spinello A; Magistrato A
    Expert Opin Drug Discov; 2022 Oct; 17(10):1095-1109. PubMed ID: 35983696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
    Sahin I; George A; Seyhan AA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RNA splicing modulation: Therapeutic progress and perspectives].
    Saoudi A; Goyenvalle A
    Med Sci (Paris); 2021; 37(6-7):625-631. PubMed ID: 34180822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.
    Garanto A; Collin RWJ
    Methods Mol Biol; 2018; 1715():61-78. PubMed ID: 29188506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
    Mourich DV; Iversen PL
    Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles and correction of 5'-splice site selection.
    Malard F; Mackereth CD; Campagne S
    RNA Biol; 2022 Jan; 19(1):943-960. PubMed ID: 35866748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.
    Adachi H; Hengesbach M; Yu YT; Morais P
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward therapy with antisense-mediated splicing modulation.
    Du L; Gatti RA
    Curr Opin Mol Ther; 2009 Apr; 11(2):116-23. PubMed ID: 19330717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Trans-Splicing Modulation via Antisense Molecule Interference.
    Liemberger B; Piñón Hofbauer J; Wally V; Arzt C; Hainzl S; Kocher T; Murauer EM; Bauer JW; Reichelt J; Koller U
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Splicing in the Treatment of Human Disease.
    Suñé-Pou M; Prieto-Sánchez S; Boyero-Corral S; Moreno-Castro C; El Yousfi Y; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Genes (Basel); 2017 Feb; 8(3):. PubMed ID: 28245575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine.
    Rahman MA; Nasrin F; Bhattacharjee S; Nandi S
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting RNA splicing for disease therapy.
    Havens MA; Duelli DM; Hastings ML
    Wiley Interdiscip Rev RNA; 2013; 4(3):247-66. PubMed ID: 23512601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.
    Blijlevens M; Li J; van Beusechem VW
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.